celastrol has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; He, XH; Hu, B; Li, YP; Liang, QQ; Ouyang, DY; Shi, ZJ; Xu, LH; Xu, R; You, YP; Yuan, T; Zha, QB; Zhang, HR | 1 |
| Dai, W; Li, C; Teng, H; Wang, B; Wang, J; Wang, X | 1 |
2 other study(ies) available for celastrol and Acute Disease
| Article | Year |
|---|---|
Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Topics: Acute Disease; Animals; Apoptosis; Caspases; Ceruletide; Mice; Necroptosis; Pancreatitis; Pentacyclic Triterpenes; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases | 2023 |
Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Female; Humans; Inflammation; Interleukin-18; Lipopolysaccharides; Microglia; Neuroprotective Agents; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Pyroptosis; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Triterpenes | 2019 |